Portenoy R, Hagen N. Breakthrough pain: definition and management. Oncology. 1989;3:25–9.
PubMed
CAS
Google Scholar
Portenoy R, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81(1):129–34.
Article
PubMed
CAS
Google Scholar
Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. Breakthrough cancer pain. BMJ. 2008;337(7681):1252.
Google Scholar
Burton B, Zeppetella G. Assessing the impact of breakthrough cancer pain. Br J Nurs. 2011;20(Sup5):S14–9.
Article
PubMed
Google Scholar
Payne R. Recognition and diagnosis of breakthrough pain. Pain Med. 2007;8(suppl 1):S3–7.
Article
PubMed
Google Scholar
Porta-Sales J, Garzón Rodríguez C, Julià Torras J, Casals Merchán M. Dolor irruptivo en cáncer. Med Clin (Barc). 2010;135(6):280–5.
Article
Google Scholar
Zampi M, Morabito A, Salvato F, Vinciguerra A. Breakthrough pain: the importance of baseline analgesic regimen with opioids. Transl Med UniSa. 2012;3:62–6.
PubMed
PubMed Central
Google Scholar
Mercadante S, Zagonel V, Breda E, Arcara C, Gebbia V, Porzio G, et al. Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manag. 2010;40(2):183–90.
Article
Google Scholar
Greco MT, Corli O, Montanari M, Deandrea S, Zagonel V, Apolone G. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer pain outcome research study group. Clin J Pain. 2011;27(1):9–18.
Article
PubMed
Google Scholar
Mercadante S, Costanzo BV, Fusco F, Buttà V, Vitrano V. Breakthrough pain in advanced cancer patients followed at home: a longitudinal study. J Pain Symptom Manag. 2009;38(4):554–60.
Article
Google Scholar
Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manag. 2013;46(5):619–28.
Article
Google Scholar
Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manag. 2014;47(1):57–76.
Article
Google Scholar
Haugen D, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S. Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain. 2010;149(3):476–82.
Porta-Sales J, Pérez C, Escobar Y, Martínez V. Diagnosis and management of breakthrough cancer pain: have all the questions been resolved? A Delphi-based consensus assessment (DOIRON). Clin Transl Oncol. 2015;18(9):945–54.
Article
PubMed
CAS
Google Scholar
Boceta J, De la Torre A, Samper D, Farto M, Sánchez-de la Rosa R. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study. Clin Transl Oncol. 2016;18(11):1088–97.
Article
PubMed
PubMed Central
CAS
Google Scholar
Løhre ET, Klepstad P, Bennett MI, Brunelli C, Caraceni A, Fainsinger RL, et al. From "breakthrough" to "episodic" Cancer pain? A European Association for Palliative Care Research Network Expert Delphi Survey toward a common terminology and classification of transient Cancer pain exacerbations. J Pain Symptom Manag. 2016;51(6):1013–9.
Article
Google Scholar
Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S. What to do, and what not to do, when diagnosing and treating breakthrough Cancer pain (BTcP): expert opinion. Drugs 2016;76(3):315–330.
Hagen NA, Stiles C, Nekolaichuk C, Biondo P, Carlson LE, Fisher K, et al. The Alberta breakthrough pain assessment tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews. J Pain Symptom Manag. 2008;35(2):136–52.
Article
Google Scholar
Webber K, Davies AN, Zeppetella G, Cowie MR. Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. J Pain Symptom Manag. 2014;48(4):619–31.
Article
Google Scholar
Samolsky Dekel BG, Remondini F, Gori A, Di Nino G, Melotti RM. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients. Clin Neurol Neurosurg. 2016;141:23–9.
Article
PubMed
Google Scholar
Davies A, Dickman A, Reid C, Stevens A, Zeppetella G. The management of cancer-related breakthrough pain: recommendations of a task group of the science Committee of the Association for palliative medicine of great Britain and Ireland. Eur J Pain. 2009;13:331–8.
Article
PubMed
Google Scholar
Webber K, Davies AN, Cowie MR. Accuracy of a diagnostic algorithm to diagnose breakthrough cancer pain as compared with clinical assessment. J Pain Symptom Manag. 2015;50(4):495–500.
Article
Google Scholar
Daeninck P, Gagnon B, Gallagher R, Henderson J, Shir Y, Zimmermann C. Canadian recommendations for the management of breakthrough cancer pain. Curr Oncol. 2016;23(2):96–108.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hiermstad M, Kassa S, Caraceni A, Loge J, Pedersen T, Haugen D, et al. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016;6(3):344–52.
Article
Google Scholar
Potter MB. Opioids for management of breakthrough pain in cancer patients. Am Fam Physician. 2006;74(11):1855–7.
PubMed
Google Scholar
William L, MacLeod R. Management of breakthrough pain in patients with cancer. Drugs. 2008;68:913–24.
Article
PubMed
CAS
Google Scholar
Laverty D. Treating cancer-related breakthrough pain: the oral transmucosal route. Int J Palliat Nurs. 2007;13(7):326–31.
Article
PubMed
Google Scholar
Mercadante S, Radbruch L, Davies A, Poulain P, Sitte T, Perkins P, et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Curr Med Res Opin. 2009;25(11):2805–15.
Article
PubMed
CAS
Google Scholar
Grape S, Schug SA, Lauer S, Schug BS. Formulations of fentanyl for the management of pain. Drugs. 2010;70(1):57–72.
Article
PubMed
CAS
Google Scholar
Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. In: Cochrane database of systematic reviews. Wiley-Blackwell; 2013.
Google Scholar
Escobar Y, Mañas A, Juliá J, Gálvez R, Zaragozá F, Margarit C, et al. Optimal management of breakthrough cancer pain (BCP). Clin Transl Oncol. 2012;15(7):526–34.
Article
PubMed
CAS
Google Scholar
Davies A, Kleeberg UR, Jarosz J, Mercadante S, Poulain P. Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain. Support Care Cancer. 2015;23(7):2135–43.
Article
PubMed
Google Scholar
Núñez-Olarte JM, Alvarez-Jiménez P. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain. J Pain Symptom Manag. 2011;42(6):e6–8.
Article
Google Scholar
Granata R, Bossi P, Bertulli R, Saita L. Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse. Pain Med. 2014;15(5):758–61.
Article
PubMed
Google Scholar
Nekolaichuk CL, Fainsinger RL, Lawlor P. A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton classification system for Cancer pain. Palliat Med. 2005;19(6):466–76.
Article
PubMed
Google Scholar
Fainsinger RL, Nekolaichuk CL. A «TNM» classification system for cancer pain: the Edmonton classification system for Cancer pain (ECS-CP). Support Care Cancer. 2008;16(6):547–55.
Nekolaichuk CL, Fainsinger RL, Aass N, Hjermstad MJ, Knudsen AK, Klepstad P, et al. The Edmonton classification system for Cancer pain: comparison of pain classification features and pain intensity across diverse palliative care settings in eight countries. J Palliat Med. 2013;16(5):516–23.
Article
PubMed
Google Scholar
Boceta J, De la Torre A, Samper D, Farto M. Sánchez-de la Rosa R. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study. Clin Transl Oncol. 2016;18(11):1088–97.
Article
PubMed
PubMed Central
CAS
Google Scholar
Martínez De La Iglesia J, Herrero RD, Vilches MCO, Taberné CA, Colomer CA, Luque RL. Adaptación y validación al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 años. Med Clin (Barc). 2001;117(4):129–34.
Article
Google Scholar
Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23(10):433–41.
Article
PubMed
CAS
Google Scholar
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J febrer. 1965;14:61–5.
CAS
Google Scholar
Cid-Ruzafa J, Damián-Moreno J. Valoración de la discapacidad física: el índice de Barthel. Rev Esp Salud Publica. 1997;71(2):127–37.
Article
PubMed
CAS
Google Scholar
Ho F, Lau F, Downing MG, Lesperance M. A reliability and validity study of the palliative performance scale. BMC Palliat Care. 2008;7(1):10.
Article
PubMed
PubMed Central
Google Scholar
Barallat E, Nabal M, Canal J, Trujillano J, Gea-Sánchez M, Larkin PJ, et al. The Spanish adaptation of the palliative performance scale (version 2) among Cancer patients at the end of life: psychometric properties. J Pain Symptom Manag. 2017;54(4):570–7.
Article
Google Scholar
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathi pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36.
Article
PubMed
Google Scholar
Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, et al. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes. 2007;5:66.
Article
PubMed
PubMed Central
Google Scholar
National Comprehensive Cancer Network Guideline for Patients. Distress. 2017 on: https://www.nccn.org/patients/guidelines/distress/files/assets/common/downloads/files/distress.pdf. Accessed 7 Jan 2018.
Mayfield D, McLeol G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatr. 1974;131(10):1121–3.
PubMed
CAS
Google Scholar
IBM Corp. IBM SPSS Statistics for Windows v. 20.0. Armonk, NY: IBM Corp; 2011.
Google Scholar
Margarit C, Juliá J, López R, Anton A, Escobar Y, Casas A, et al. Breakthrough cancer pain - still a challenge. J Pain Res. 2012;5:559–66.
Article
PubMed
PubMed Central
Google Scholar
Parsons H, Delgado-Guay M, El Osta B, Chacko R, Poulter V, Palmer J. Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med. 2008;11(7):964–8.
Article
PubMed
PubMed Central
Google Scholar
Dev R, Parsons H, Palla S, Palmer J, Del Fabbro E, Bruera E. Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer. 2011;117(19):4551–6.
Article
PubMed
PubMed Central
Google Scholar
Chow E, Connolly R, Wong R, Franssen E, KW F, Harth T. Use of the CAGE questionnaire for screening problem drinking in an out-patient palliative radiotherapy clinic. J Pain Symptom Manag. 2001;21(6):491–7.
Article
CAS
Google Scholar
Arthur J, Yennurajalingam S, Nguyen L, Tanco K, Chisholm G, Hui D. The routine use of the Edmonton classification system for Cancer pain in an outpatient supportive care center. Palliat Support Care. 2015;13(5):1185–92.
Article
PubMed
Google Scholar